<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2268">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05131633</url>
  </required_header>
  <id_info>
    <org_study_id>WEEK'ALR</org_study_id>
    <nct_id>NCT05131633</nct_id>
  </id_info>
  <brief_title>Regional Anaesthesia in Intensive Care Unit</brief_title>
  <acronym>Week'ALR</acronym>
  <official_title>Point-of-care Regional Anaesthesia in Intensive Care Unit. A Multicentric Professional Practice Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hôpital Edouard Herriot</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rangueil Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Louis Pradel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Saint Camille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital de la Timone</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint Antoine University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Strasbourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CH Aix</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CH Martigues</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CH Alberville</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CH Chambery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bichat Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain is a major problem in Intensive Care Unit (ICU). Adequate pain management not only means&#xD;
      decreasing the pain intensity, but also improving the functionality and allowing the early&#xD;
      mobilization that is a prerequisite for improving recovery and decreasing the risk of&#xD;
      complications in ICU. The complex problems involved in pain, analgesic interventions, and&#xD;
      outcome have been emphasized in several surveys over the past decades, but apparently with&#xD;
      only small improvements, despite the existence of several guidelines for perioperative pain&#xD;
      management.&#xD;
&#xD;
      Regional analgesia techniques (peripheral and neuraxial nerve blocks) have the potential to&#xD;
      decrease the physiological stress response to trauma or surgery, reducing the possibility of&#xD;
      surgical complications and improving the outcomes. Recent studies suggested that surgical and&#xD;
      trauma ICU patients receive opioid-hypnotics continuous infusions to prevent pain and&#xD;
      agitation that could increase the risk of posttraumatic stress disorder and chronic&#xD;
      neuropathic pain symptoms, and chronic opioid use. Also they may reduce the total amount of&#xD;
      opioid analgesics necessary to achieve adequate pain control and the development of&#xD;
      potentially dangerous side effects. The use of the regional anesthesia technique in the ICU,&#xD;
      however, can, in part, be limited by the presence of hemodynamic instability, bleeding&#xD;
      diathesis, and by the fear of the performing procedures potentially associated with&#xD;
      significant side effects in heavily sedated patients.&#xD;
&#xD;
      Although regional anesthesia emerges as a new and very interesting player for pain management&#xD;
      in ICU, today very few data exists about the use of RA (including PNB and neuraxial nerves&#xD;
      blocks) by the practicians in ICU/stepdown units. The main objective of this study is to&#xD;
      assess the use of RA for pain management both initiates in the operative room for surgical&#xD;
      patients then transferred in ICU/stepdown units and performs directly by the practicians in&#xD;
      ICU/stepdown units, in several french units.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Taken together, previous data indicate that regional anesthesia emerges as a new and very&#xD;
      interesting player for pain management in ICU.&#xD;
&#xD;
      Because very few data exist about the use of RA (including PNB and neuraxial nerves blocks)&#xD;
      by the practicians in ICU we, therefore, design this multicentric professional practice&#xD;
      evaluation to :&#xD;
&#xD;
        -  (1) , assess the use of RA in ICU/stepdown units but initiates by anesthesiologist in&#xD;
           the operative room&#xD;
&#xD;
        -  (2) , assess the use of RA in ICU/stepdown units directly perform by practicians in ICU&#xD;
&#xD;
        -  (3) , describe the type, modalities and indications of RA performed&#xD;
&#xD;
      This study will have no effect on the management of the ICU/stepdown units patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Our primary objective is to assess the global use of RA in ICU/stepdown units</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>. Number (prevalence) of RA performed in ICU over 1 week.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assess the use, in ICU/stepdown units patients, of RA previously initiated in the operative room by an anesthesiologist</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>.Number of RA performed in operative room and then transferred in ICU over a week.&#xD;
. Prevalence of RA performed in the operative room and then transferred in ICU over a week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Nerves block or spinal anesthesia or epidural anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>ICU or step-down unit or operating room</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Who perform RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Resident or senior and intensivist or anesthesiologist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Name of local anesthetics used</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Name of local anesthetics used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of local anesthetics used</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Concentration in mg/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Indications for RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Analgesia or anesthesia or mobilization or nursing or weaning from mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical management to perform RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Type of needle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical management to perform RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Use of sonography (yes / no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical management to perform RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Use of electrical nerve stimulator (yes / no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical management to perform RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Use of continuous catheter (yes / no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of analgesia</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Visual Analog Score for pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of success or not in RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Sensitive and/or motor block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contraindication for RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Type of contraindication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication of RA</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Type of complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reason for removal cathete</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Type of reason</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of catheter</measure>
    <time_frame>During 1 week of the study</time_frame>
    <description>Duration in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU/stepdown units length of stay</measure>
    <time_frame>Day 28 after the RA</time_frame>
    <description>Length in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Day 28 after the RA</time_frame>
    <description>Length in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of vital status: on ICU/stepdown units discharge</measure>
    <time_frame>Day 28 after the RA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of vital status at day 28</measure>
    <time_frame>Day 28 after the RA</time_frame>
    <description>Death or alive</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free days to day 28</measure>
    <time_frame>Day 28 after the RA</time_frame>
    <description>Unit : days</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intensive Care Unit</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All medical, surgical, and trauma patients hospitalized in the participating centers and&#xD;
        receiving RA during the one-week study period.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ○ All medical, surgical, and trauma patients hospitalized in the participating centers and&#xD;
        receiving RA during the one-week study period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Opposition to the processing of personal data&#xD;
&#xD;
          -  Age &lt;18 years old&#xD;
&#xD;
          -  Absolute contraindications to the perform RA&#xD;
&#xD;
          -  Previous hypersensitivity or anaphylactic reaction to local anesthetics&#xD;
&#xD;
          -  Patient under a tutelage measure or placed under judicial protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Raïko Blondonnet</last_name>
    <role>Principal Investigator</role>
    <affiliation>rblondonnet@chu-clermontferrand.fr</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lise Laclautre</last_name>
    <phone>+33 4 73 754963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raiko Blondonnet</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Aix-En-Provence</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Ronfle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Bry-sur-Marne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Carreira</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Chambéry</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Sauvajon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raïko Blondonnet</last_name>
      <email>rblondonnet@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Jean-Perrin</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Bauer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre Lemaire</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilles Francony</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Lagarde</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Kipnis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCL Centre des Grands Brulés</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rémi Schweizer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCL Hôpital Sud</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donatien Marignan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérémy Bourenne</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHM Nord</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Zieleskiewicz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Muller</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AHPH Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Gutton</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP Bichat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sacha Rozencwajg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Legros</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoann Launey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH</name>
      <address>
        <city>Saint-Grégoire</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Fusco</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny Planquart</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali Centelles</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 3, 2021</study_first_submitted>
  <study_first_submitted_qc>November 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Clermont-Ferrand</investigator_affiliation>
    <investigator_full_name>Blondonnet Raïko</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>regional anesthesia</keyword>
  <keyword>intensive care unit</keyword>
  <keyword>analgesia</keyword>
  <keyword>pain management</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

